Strata Skin Sciences, Inc.
SSKN
$2.89
$0.2911.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.68M | 32.73M | 32.55M | 33.36M | 35.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.68M | 32.73M | 32.55M | 33.36M | 35.27M |
| Cost of Revenue | 14.55M | 14.96M | 15.39M | 14.90M | 14.76M |
| Gross Profit | 18.13M | 17.77M | 17.15M | 18.46M | 20.51M |
| SG&A Expenses | 23.25M | 21.85M | 22.53M | 23.46M | 24.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.86M | 37.88M | 39.17M | 39.68M | 40.30M |
| Operating Income | -6.19M | -5.15M | -6.62M | -6.32M | -5.03M |
| Income Before Tax | -9.48M | -8.41M | -11.46M | -10.92M | -7.13M |
| Income Tax Expenses | -92.00K | -92.00K | -92.00K | -92.00K | 63.00K |
| Earnings from Continuing Operations | -9.38 | -8.31 | -11.36 | -10.83 | -7.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.38M | -8.31M | -11.36M | -10.83M | -7.20M |
| EBIT | -6.19M | -5.15M | -6.62M | -6.32M | -5.03M |
| EBITDA | -1.17M | 80.00K | -1.22M | -767.00K | 567.00K |
| EPS Basic | -2.60 | -2.37 | -3.25 | -3.10 | -2.06 |
| Normalized Basic EPS | -1.39 | -1.25 | -1.48 | -1.38 | -1.12 |
| EPS Diluted | -2.60 | -2.37 | -3.25 | -3.10 | -2.06 |
| Normalized Diluted EPS | -1.39 | -1.25 | -1.48 | -1.38 | -1.12 |
| Average Basic Shares Outstanding | 14.55M | 14.01M | 13.99M | 13.97M | 13.94M |
| Average Diluted Shares Outstanding | 14.55M | 14.01M | 13.99M | 13.97M | 13.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
